Ares Commercial Real Estate Corporation
NYSE:ACREREIT - Mortgage
+$0.04 today
- Market cap
- $192.00M
- Beta
- 1.20
- P/E (TTM)
- -12.9
- EPS (TTM)
- -$0.36
- Dividend yield
- 12.92%
Volume 0.47M
Average 0.41M
ACRE Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Ares Commercial Real Estate CorporationNYSE: ACRE
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | -100.0% |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How ACRE compares with its peers on the latest reported figures
- ACRE's LTM Mar 2026 research & development of $0 is the highest of the 9 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for ACRE, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
MITNTPG Mortgage Investment Trust Inc 9.500% Senior Notes due 2029 | LTM Mar 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ACRE) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for ACRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 102.07M | 109.05M | 1.1M | 87.8M | 85.35M |
| Cost of Revenue | 18.56M | 0 | 0 | 0 | 36.4M |
| Gross Profit | 83.51M | 109.05M | 1.1M | 87.8M | 48.95M |
| Gross Margin | 81.8% | 100.0% | 100.0% | 100.0% | 57.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 7.76M | 10.17M | 26M | 24.97M | 9.8M |
| Operating Expenses | (40.89M) | 109.05M | 26M | 24.97M | (12.83M) |
| Depreciation & Amortization | 39.22M | 7.1M | 1.02M | 5.41M | 8.4M |
| EBITDA | 61.18M | 7.1M | 1.02M | 5.41M | 70.19M |
| EBITDA Margin | 59.9% | 6.5% | 92.3% | 6.2% | 82.2% |
| Operating Income | 61.18M | 0 | (24.89M) | 62.84M | 61.79M |
| Operating Margin | 59.9% | 0.0% | -2261.0% | 71.6% | 72.4% |
| Interest Income | 133.63M | 170.17M | 206.16M | 157.72M | 97.59M |
| Interest Expense | 50.08M | 65.99M | 117.2M | 105.99M | 65.16M |
| Other Income / Expenses | (18.55M) | 30.26M | (14.01M) | (97.85M) | (62.4M) |
| Income Before Tax | 61.18M | 30.26M | 38.91M | 35.01M | (617K) |
| Pre-Tax Margin | 59.9% | 27.7% | 3533.7% | 39.9% | -0.7% |
| Income Tax Expense | 722K | 472K | 39K | 18K | 285K |
| Net Income | 60.46M | 29.79M | (38.87M) | (34.99M) | (902K) |
| Net Margin | 59.2% | 27.3% | -3530.2% | -39.9% | -1.1% |
| EPS (Basic) | 1.43 | 0.58 | (0.72) | (0.64) | (0.02) |
| EPS (Diluted) | 1.42 | 0.57 | (0.72) | (0.64) | (0.02) |
| Weighted Avg Shares | 42.4M | 51.68M | 54.28M | 54.45M | 54.89M |
| Weighted Avg Shares (Diluted) | 42.68M | 52.13M | 54.28M | 54.45M | 54.89M |
Ares Commercial Real Estate Corporation
NYSE:ACRE
Intrinsic Alpha fair value
Locked
Current Price
$3.46
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.